Gro Haarklou Mathisen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gro Haarklou Mathisen has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Sebastian Hoffmann
Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins University, Bloomberg School of Public Health
10 shared publications - Heather Ames
Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health
9 shared publications - Paul Whaley
Lancaster Environment Centre, Lancaster University, Lancaster, United Kingdom
9 shared publications - Trine Husøy
Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health
8 shared publications - Camilla Svendsen
Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health
7 shared publications Gunn E. Vist
7 shared publications
Latest Publications
- Open Access
- 24 July 2026
- Published by Elsevier in NAM Journal
- Vol. 2
Modelling the regulatory toxicology system to promote the effective use of new approach methodologies: a system thinking approach
- 24 July 2026
- Published by Elsevier in NAM Journal
- Vol. 2
Open AccessModelling the regulatory toxicology system to promote the effective use of new approach methodologies: a system thinking approach
- Open Access
- 20 July 2026
- Published by Elsevier in NAM Journal
- Vol. 2
Preparing for CHANGE: How systems thinking supports an effective transition from animal studies to NAMs
- 20 July 2026
- Published by Elsevier in NAM Journal
- Vol. 2
Open AccessPreparing for CHANGE: How systems thinking supports an effective transition from animal studies to NAMs
- 20 July 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 171
External validity for in vitro toxicity studies: an important but challenging concept
- 20 July 2026
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 171
External validity for in vitro toxicity studies: an important but challenging concept
- Open Access
- 9 September 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (12) , 1-22
Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologies
The transition from traditional animal-based approaches and assessments to New Approach Methodologies (NAMs) marks a scientific revolution in regulatory toxicology, with the potential of enhancing human and environmental protection. However, implementing the effective use of NAMs in regulatory toxicology has proven to be challenging, and so far, efforts to facilitate this change frequently focus on singular technical, psychological or economic inhibitors. This article takes a system-thinking approach to these challenges, a holistic framework for describing interactive relationships between the components of a system of interest. In this case, the regulatory toxicology system. We do so by analysing and interpreting a very large qualitative data set of experts’ observations, collected in a 3-day interactive workshop and three follow-up online workshops with a heterogeneous sample of experts representing major actors from the global regulatory toxicology system. We identified leverage points (where a small change within a system can have a disproportionately large effect) in the six core aspects—infrastructure, processes, culture, technology, goals, and actors—in the regulatory toxicology system to facilitate the effective use of NAMs. Identified systematic leverage points include the need for a functioning incentive structure for effectively discovering, developing, validating and using NAMs within academia, regulation, and industry; and measures that prevent or mitigate unwanted effects of using NAMs that acknowledge clashes between scientific, regulatory, political and social processes. The results serve as a basis for follow-up activities that reflect on the actual effectiveness of these levers and that develop measures for the regulatory toxicology system.
- 9 September 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (12) , 1-22
Open AccessExploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologies
The transition from traditional animal-based approaches and assessments to New Approach Methodologies (NAMs) marks a scientific revolution in regulatory toxicology, with the potential of enhancing human and environmental protection. However, implementing the effective use of NAMs in regulatory toxicology has proven to be challenging, and so far, efforts to facilitate this change frequently focus on singular technical, psychological or economic inhibitors. This article takes a system-thinking approach to these challenges, a holistic framework for describing interactive relationships between the components of a system of interest. In this case, the regulatory toxicology system. We do so by analysing and interpreting a very large qualitative data set of experts’ observations, collected in a 3-day interactive workshop and three follow-up online workshops with a heterogeneous sample of experts representing major actors from the global regulatory toxicology system. We identified leverage points (where a small change within a system can have a disproportionately large effect) in the six core aspects—infrastructure, processes, culture, technology, goals, and actors—in the regulatory toxicology system to facilitate the effective use of NAMs. Identified systematic leverage points include the need for a functioning incentive structure for effectively discovering, developing, validating and using NAMs within academia, regulation, and industry; and measures that prevent or mitigate unwanted effects of using NAMs that acknowledge clashes between scientific, regulatory, political and social processes. The results serve as a basis for follow-up activities that reflect on the actual effectiveness of these levers and that develop measures for the regulatory toxicology system.
- Open Access
- 5 September 2025
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 3 (1)
Identification of concepts of importance for the assessment of internal validity of in vitro toxicology studies using a modified Delphi technique
- 5 September 2025
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 3 (1)
Open AccessIdentification of concepts of importance for the assessment of internal validity of in vitro toxicology studies using a modified Delphi technique
- Open Access
- 6 May 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (8) , 3453-3461
Improving how we use workshops when solving complex research problems: reflections from the CHANGE project
Organising workshops that successfully address complex research problems is a challenge, especially when the research involves interest-holders with diverse roles and expertise and potentially conflicting values and viewpoints. In this article, we describe and reflect on the approach we took to organising the CHANGE workshop, held in Oslo in June 2024. CHANGE is a complex 3-year project involving the collecting, analysing, and developing cross-sector consensus on a challenging topic. The approaches on which we reflect include fundamental aspects of interest-holder engagement, workshop design, methodological approach, and inclusive participation. Based on our reflections, we present a series of recommendations for consideration by anyone in the general research community using workshops as part of a research process.
- 6 May 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (8) , 3453-3461
Open AccessImproving how we use workshops when solving complex research problems: reflections from the CHANGE project
Organising workshops that successfully address complex research problems is a challenge, especially when the research involves interest-holders with diverse roles and expertise and potentially conflicting values and viewpoints. In this article, we describe and reflect on the approach we took to organising the CHANGE workshop, held in Oslo in June 2024. CHANGE is a complex 3-year project involving the collecting, analysing, and developing cross-sector consensus on a challenging topic. The approaches on which we reflect include fundamental aspects of interest-holder engagement, workshop design, methodological approach, and inclusive participation. Based on our reflections, we present a series of recommendations for consideration by anyone in the general research community using workshops as part of a research process.
- Open Access
- 31 October 2024
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 2 (1) , 2418045
A comprehensive item bank of internal validity issues of relevance to in vitro toxicology studies
In vitro toxicology studies are increasingly being included as evidence in systematic reviews and chemical risk assessments. INVITES-IN, a tool for assessing the internal validity of in vitro studies, is currently under development. The first step in developing INVITES-IN involves the creation of an “item bank,” an overview of study assessment concepts that may be relevant to evaluating the internal validity of in vitro toxicology studies. The item bank and methodology for its creation presented in this manuscript are intended to be a general resource for supporting the development of appraisal tools for in vitro toxicology studies and potentially other study designs. We derived the item bank from seven literature sources (one existing item bank created from a systematic review of assessment criteria for in vitro studies, and six purposively sampled study appraisal tools) and the transcripts of three focus groups. Assessment criteria plausibly relating to internal validity were abstracted from the literature sources and focus group transcripts, disaggregated into individual criteria, then normalised to express in the simplest achievable language the core issue in each criterion – an “item bank” of assessment concepts. The items were then mapped onto a set of bias domains. We conducted simple descriptive statistical analyses and visualisations to describe patterns in the dataset and developed recommendations for the use and development of the item bank. The item bank contains 405 items of potential relevance to evaluating the internal validity of in vitro toxicology studies. To our knowledge, this is the second item bank of any kind to have been created for toxicology studies, and the first to use focus groups as a data source alongside literature analysis. The large number of items contributed by focus group discussions suggests this is an efficient method for capturing internal validity issues that are not easily identifiable in the literature. We believe our item bank and methodology for its creation will be a useful resource for supporting the development of appraisal tools. Due to the broad applicability of many items in the item bank, it may be informative for study designs beyond the in vitro domain.
- 31 October 2024
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 2 (1) , 2418045
Open AccessA comprehensive item bank of internal validity issues of relevance to in vitro toxicology studies
In vitro toxicology studies are increasingly being included as evidence in systematic reviews and chemical risk assessments. INVITES-IN, a tool for assessing the internal validity of in vitro studies, is currently under development. The first step in developing INVITES-IN involves the creation of an “item bank,” an overview of study assessment concepts that may be relevant to evaluating the internal validity of in vitro toxicology studies. The item bank and methodology for its creation presented in this manuscript are intended to be a general resource for supporting the development of appraisal tools for in vitro toxicology studies and potentially other study designs. We derived the item bank from seven literature sources (one existing item bank created from a systematic review of assessment criteria for in vitro studies, and six purposively sampled study appraisal tools) and the transcripts of three focus groups. Assessment criteria plausibly relating to internal validity were abstracted from the literature sources and focus group transcripts, disaggregated into individual criteria, then normalised to express in the simplest achievable language the core issue in each criterion – an “item bank” of assessment concepts. The items were then mapped onto a set of bias domains. We conducted simple descriptive statistical analyses and visualisations to describe patterns in the dataset and developed recommendations for the use and development of the item bank. The item bank contains 405 items of potential relevance to evaluating the internal validity of in vitro toxicology studies. To our knowledge, this is the second item bank of any kind to have been created for toxicology studies, and the first to use focus groups as a data source alongside literature analysis. The large number of items contributed by focus group discussions suggests this is an efficient method for capturing internal validity issues that are not easily identifiable in the literature. We believe our item bank and methodology for its creation will be a useful resource for supporting the development of appraisal tools. Due to the broad applicability of many items in the item bank, it may be informative for study designs beyond the in vitro domain.
- Open Access
- 12 July 2024
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 2 (1)
Cross-mapping of terms used in chemical risk assessment with those used in systematic review: research protocol
The focus on implementation of systematic review (SR) principles in chemical risk assessments (CRAs) is growing as it has the potential to advance the rigour and transparency of the CRAs. However, the SR and CRA communities use their own specific terminologies. Understanding the meaning of core SR and CRA terms and where they overlap is critical for application of SR methods and principles in CRAs. Moreover, it will increase the possibility for cross-sectorial collaboration, avoid misunderstandings, and improve communication among risk assessors, researchers, and policy makers. We present a process for the cross-mapping of core CRA terms and core SR terms. Core terms for study appraisal, evidence synthesis and integration used in the SR and CRA communities will be included. The outcome will be an overview of how core SR terms map onto core CRA terms and vice versa, and a description of the relationship and conceptual overlap between the terms. The cross-mapping is divided in three phases, where in the first phase the core SR and CRA terms will be identified. In the second phase, existing SR and CRA definitions will be mapped. In the third phase, descriptions of the relationship and conceptual overlap between the terms will be derived. The third phase will include weekly one-hour online meetings for SR and CRA experts.
- 12 July 2024
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 2 (1)
Open AccessCross-mapping of terms used in chemical risk assessment with those used in systematic review: research protocol
The focus on implementation of systematic review (SR) principles in chemical risk assessments (CRAs) is growing as it has the potential to advance the rigour and transparency of the CRAs. However, the SR and CRA communities use their own specific terminologies. Understanding the meaning of core SR and CRA terms and where they overlap is critical for application of SR methods and principles in CRAs. Moreover, it will increase the possibility for cross-sectorial collaboration, avoid misunderstandings, and improve communication among risk assessors, researchers, and policy makers. We present a process for the cross-mapping of core CRA terms and core SR terms. Core terms for study appraisal, evidence synthesis and integration used in the SR and CRA communities will be included. The outcome will be an overview of how core SR terms map onto core CRA terms and vice versa, and a description of the relationship and conceptual overlap between the terms. The cross-mapping is divided in three phases, where in the first phase the core SR and CRA terms will be identified. In the second phase, existing SR and CRA definitions will be mapped. In the third phase, descriptions of the relationship and conceptual overlap between the terms will be derived. The third phase will include weekly one-hour online meetings for SR and CRA experts.
- Open Access
- 14 June 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (8) , 2299-2308
Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology
- 14 June 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (8) , 2299-2308
Open AccessTime for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology
- Open Access
- 31 December 2023
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 1 (1)
Protocol: Testing the Performance of INVITES-IN, A Tool for Assessing the Internal Validity of In Vitro Studies
- 31 December 2023
- Published by Taylor & Francis in Evidence-Based Toxicology
- Vol. 1 (1)
Open AccessProtocol: Testing the Performance of INVITES-IN, A Tool for Assessing the Internal Validity of In Vitro Studies